首页> 外文OA文献 >X-Linked Lymphoproliferative Syndrome and Common Variable Immunodeficiency May Not Be Differentiated by SH2D1A and XIAP/BIRC4 Genes Sequence Analysis
【2h】

X-Linked Lymphoproliferative Syndrome and Common Variable Immunodeficiency May Not Be Differentiated by SH2D1A and XIAP/BIRC4 Genes Sequence Analysis

机译:SH2D1A和XIAP / BIRC4基因序列分析可能无法区分X连锁淋巴增生综合征和常见的可变免疫缺陷

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The X-linked lymphoproliferative syndrome (XLP) is a rare, inherited immunodeficiency characterized by recurrent episodes of hemophagocytic lymphohistiocytosis, hypogammaglobulinemia, and/or lymphomas. Recently, X-linked inhibitor of apoptosis (XIAP/BIRC4) gene defects, in families with XLP but without SH2D1A gene defects, has been defined. The distinction from primary immunodeficiencies with a defined genetic cause is mandatory. A six-year-old male patient was admitted with the complaints of persistent general lymphadenopathy, for two years had fever, bilateral cervical multiple microlymphadenopathy, hepatic/splenic enlargement with laboratory findings as decreased serum immunoglobulins, negative EBV VCA IgM (viral capsid antigen) and anti-EBV EA (antibody to early D antigen), positive EBV VCA IgG (viral capsid antigen) and EBV EBNA (antibody to nuclear antigen). SH2D1A gene analysis was negative. XIAP/BIRC4 sequencing revealed two novel single nucleotide variants (exon 7, 1978G > A, and 1996T > A) in the 3′UTR of the gene in both patient and mother which were not disease causing. XIAP protein expression was found to be normal. The clinical and laboratory resemblance, no gene mutations, and normal XIAP protein expression led us to think that there may be another responsible gene for XLP. The patient will to be followed up as CVID until he presents new diagnostic signs or until the identification of a new gene.
机译:X连锁淋巴组织增生综合征(XLP)是一种罕见的遗传性免疫缺陷病,其特征是经常发生的噬血细胞性淋巴组织细胞增生症,低血球蛋白血症和/或淋巴瘤。最近,已经定义了具有XLP但没有SH2D1A基因缺陷的家族中的X连锁凋亡抑制剂(XIAP / BIRC4)基因缺陷。必须将其与具有明确遗传原因的原发性免疫缺陷区分开来。一名6岁的男性患者因持续性一般性淋巴结肿大而入院,发烧两年,双侧子宫颈多发性微淋巴结病,肝/脾肿大,实验室检查发现血清免疫球蛋白降低,EBV VCA IgM阴性(病毒衣壳抗原)以及抗EBV EA(早期D抗原抗体),阳性EBV VCA IgG(病毒衣壳抗原)和EBV EBNA(核抗原抗体)。 SH2D1A基因分析为阴性。 XIAP / BIRC4测序在患者和母亲的基因3'UTR中均发现了两个新的单核苷酸变体(外显子7,1978G> A,和1996T> A),这些变体均未引起疾病。发现XIAP蛋白表达正常。临床和实验室相似,没有基因突变,并且XIAP蛋白表达正常,这使我们认为XLP可能还有另一个负责任的基因。将对患者进行CVID随访,直到出现新的诊断体征或鉴定出新基因为止。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号